Table 2.
Patient characteristics.
| Age (years) | Median 60, range 38–83 |
| Sex | Male 7, female 10 |
| Starting dose of imatinib | 400 mg, 12 patients |
| 800 mg, 5 patients | |
| Duration of treatment, months | Median 23, range 3–39 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.